C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2001
11/21/2001	CN1323217A Methods for therapeutic vaccination
11/21/2001	CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001	CN1322837A New polypeptide human ATP dependent serine proteinase 11 and its encoding polynucleotides
11/21/2001	CN1322836A New polypeptide human ATP dependent serine proteinase 11 and its encoding polynucleotides
11/21/2001	CN1322835A New polypeptide human ATP dependent serine proteinase 12 and its encoding polynucleotides
11/21/2001	CN1322823A New polypeptide human aldehyde/ketone reductase 10 and its encoding polynucleotides
11/21/2001	CN1322817A New polypeptide human ubiquitin conjugated enzyme 10.2 and its encoding polynucleotides
11/21/2001	CN1322762A Humanized antibody with specificity to HBV surface antigen PRE-S1 and its producing process
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1322758A New polypeptide human ribosomal protein 12 and its encoding polynucleotides
11/21/2001	CN1322756A New polypeptide human Pax protein 10 and its encoding polynucleotides
11/21/2001	CN1322754A New polypeptide human Pax and protein 15 and its encoding polynucleotides
11/21/2001	CN1322751A New polypeptide human Pax protein 15 and its encoding polynucleotides
11/21/2001	CN1322739A New polypeptide human cyclophilin 11 and its encoding polynucleotides
11/21/2001	CN1322732A New liver cancer up expressing gene and its encoded protein and application
11/21/2001	CN1322730A New polypeptide-p62cdc6 protein 24 and encoding polynucleotides of the same polypeptide
11/21/2001	CN1075112C Producing process of HEV Protein and method of testing HEV infection
11/21/2001	CN1075078C Producing process of stem cell factor
11/20/2001	US6320037 IBD-associated microbial nucleic acid molecules
11/20/2001	US6320036 GbpA
11/20/2001	US6320022 Adrenomedullin peptides
11/20/2001	US6319891 Method of diagnosing and treating gliomas
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319713 Methods and compositions for polypeptide engineering
11/20/2001	US6319704 Nucleotide sequences coding an enzymatic polypeptide; for use in the diagnosis and treatment of nervous system disorders
11/20/2001	US6319700 Human choline acetyltransferase
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319690 Preparation and use of gene banks of human antibodies (“human-antibody libraries”)
11/20/2001	US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319685 Polypeptide for generation of amidated agricultral and medical products
11/20/2001	US6319677 Monitoring seed development; evaluate migration of globulins in seed extracts, migration of globulins indicates seed development activity
11/20/2001	US6319675 Methods for detecting and/or identifying agents which bind and/or modulate function of “bonzo” chemokine receptor
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	US6319502 Immunogenic polypeptide; treating malaria
11/20/2001	US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence
11/20/2001	US6319493 Treatment of neoplastic disease with interleukin-10
11/20/2001	CA2065022C Rubella peptides
11/19/2001	CA2324167A1 A membrane-bound netrin
11/18/2001	CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/18/2001	CA2477192A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/15/2001	WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085956A2 Lipid metabolism enzymes
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085954A2 Serine-threonine kinase-3
11/15/2001	WO2001085952A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001	WO2001085947A2 Compounds and methods for the diagnosis and treatment of babesia microti infection
11/15/2001	WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001	WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001	WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001	WO2001085936A1 F-box containing protein
11/15/2001	WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001	WO2001085927A1 Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum
11/15/2001	WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	WO2001085921A2 Human serine-threonine kinase-4
11/15/2001	WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
11/15/2001	WO2001085908A2 Clasp-1 transmembrane protein
11/15/2001	WO2001085905A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	WO2001085796A2 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage
11/15/2001	WO2001085795A1 Trivalent antibody constructs having variable regions that are stabilized by disulfide bridges
11/15/2001	WO2001085792A2 Mu-1, member of the cytokine receptor family
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001	WO2001085783A2 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085777A2 Therapeutic pore-forming peptides
11/15/2001	WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001	WO2001085770A2 Sentinel virus ii
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085759A1 Separation of avian antibodies
11/15/2001	WO2001085210A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001	WO2001085209A2 Treating t-cell mediated diseases by modulating dr6 activity
11/15/2001	WO2001085205A1 Compositions and methods for induction of active autoimmunity
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085201A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
11/15/2001	WO2001076627A8 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
11/15/2001	WO2001049729A8 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
11/15/2001	WO2001047518A8 Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant emap ii
11/15/2001	WO2001038350A3 85kDa NEISSERIAL ANTIGEN
11/15/2001	WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001	WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001	WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001	WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001	WO2000061636A3 Aberrantly glycosylated antibodies as marker for cancer
11/15/2001	WO2000058365A9 Specific binding proteins for treating canine allergy
11/15/2001	WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001	WO2000047627A9 Agents that bind to and inhibit human cytochrome p450 2c8, 2c9, 2c18 and 2c19
11/15/2001	US20010041680 Administering an antibody that specifically binds to EMAP(endothelial monocyte-activating polypeptides II) to the subject which needs inhibition of EMAP activity in an amount effective to stimulate vascular growth in cardiac muscle

1 ... 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 ... 1494